Simetrel is an antiviral and antiparkinsonian drug used to treat viral infections and neurological disorders. The drug is effective against influenza A virus, preventing its reproduction, and is also used to relieve symptoms of Parkinson's disease and parkinsonism caused by medications or other causes. Its action is based on a unique combination of antiviral and neurotropic properties, which makes Simetrel a valuable tool in the therapy of both acute infectious diseases and chronic neurological conditions.
Dosage | Package | Per Item | Per Pack | Order |
100 mg |
|
The brand version of Symmetrel is not available without a prescription in your region and requires a doctor’s consultation and approval.
The trade name of the drug is Symmetrel. This is the registered name under which the drug is known in medical practice and is available in pharmacies.
The international nonproprietary name is amantadine. It denotes the active active ingredient and is used internationally in pharmacology.
Simmetrel is available in two forms: capsules of 100 mg, packed in blisters of 10 pieces or bottles of 100 capsules, and syrup with a concentration of 50 mg/5 ml in 150 ml bottles with a measuring spoon. The capsules have white or slightly grayish color, and the syrup has a clear consistency with a slight fruity aroma, which facilitates its use in children and patients with swallowing difficulties.
The main active ingredient is amantadine hydrochloride. One capsule contains 100 mg of amantadine hydrochloride, and 5 ml of syrup contains 50 mg.
The capsules include lactose monohydrate, microcrystalline cellulose, magnesium stearate, and the shell consists of gelatin and titanium dioxide. The syrup contains sorbitol, sucrose, methylparaben, propylparaben (preservatives), citric acid, sodium citrate, cherry flavoring, and purified water.
Amantadine, the active ingredient of Symmetrel, has a dual mechanism of action: antiviral and neurotropic. As an antiviral agent, amantadine blocks M2 ion channels of influenza A virus, preventing the release of viral RNA into the cytoplasm of infected cells. This disrupts the replication process of the virus, reducing its spread in the body. The antiviral effect is most pronounced when treatment is started within 48 hours of the onset of flu symptoms, shortening the duration of the illness and reducing the severity of manifestations.
As an antiparkinsonian agent, amantadine acts on the central nervous system by increasing the release of dopamine from presynaptic terminals and inhibiting its reuptake. It also has a weak antagonistic effect on NMDA receptors, which helps to reduce rigidity, tremor, and bradykinesia in Parkinson's disease. The therapeutic effect in Parkinsonism is noticeable in 2-7 days, peaking in 1-2 weeks. Symmetrel does not cure Parkinson's, but it significantly improves motor function and quality of life in patients.
Amantadine is well absorbed from the gastrointestinal tract after oral administration. Maximum plasma concentrations are reached after 1-4 hours for capsules and 2-3 hours for syrup. Bioavailability is about 60-90%, and food intake does not significantly affect absorption, which allows taking the drug independently of meals.
Amantadine binds weakly to plasma proteins (about 67%), mainly to albumin. The volume of distribution is about 3-8 l/kg, indicating penetration into various tissues, including the central nervous system, lungs and salivary glands. The drug passes through the blood-brain barrier, providing its neurotropic effect, and is also excreted in breast milk.
Amantadine is metabolized to a minimal extent (less than 10%) in the liver. The bulk of the substance is excreted unchanged, which distinguishes it from many other drugs. A small amount is metabolized to N-acetylamantadine, which has no significant pharmacological activity.
The half-life of amantadine is 10-31 hours (average 15 hours) in patients with normal renal function. The drug is excreted mainly through kidneys (about 90% in unchanged form) by tubular filtration and tubule secretion. Complete excretion takes about 3-5 days, but in case of renal dysfunction this period increases.
Simetrel is indicated for the treatment of the following conditions:
The drug is effective in controlling symptoms and preventing viral infections.
The use of Simetrel is prohibited in:
Cautious prescribing in glaucoma, psychosis, hepatic dysfunction.
Symmetrel capsules are taken orally, drinking water (100-150 ml), regardless of meals. Syrup is measured with a spoon and taken orally, preferably in the morning and afternoon to avoid insomnia. Capsules should not be chewed or opened to preserve the stability of the active ingredient.
Flu: 100 mg once daily for 4-5 days (treatment) or 10-14 days (prophylaxis). In Parkinson's: 100 mg once daily for 3 days, then 100 mg twice daily, up to a maximum of 400 mg/day, course determined by a doctor.
In influenza: 1-9 years - 2-4 mg/kg body weight per day (maximum 100 mg); 10-12 years - 100 mg 1 time per day. In Parkinson's in children is not used.
In renal insufficiency: creatinine clearance 30-50 ml/min - 100 mg every other day; 15-29 ml/min - 100 mg once every 7 days. In hepatic insufficiency correction is not required, but monitoring of the condition is necessary.
Possible adverse reactions include:
Side effects are more common in the elderly and require monitoring.
Doses above 400-600 mg/day may cause agitation, convulsions, arrhythmias, hypotension, hallucinations.
Stop taking, call an ambulance. Gastric lavage, give activated charcoal. Symptomatic treatment in hospital is required.
Simmetrel enhances the effects of anticholinergics and levodopa, increasing the risk of side effects. Alcohol and CNS stimulants increase agitation. Diuretics (triamterene) reduce the excretion of amantadine.
Alcohol increases CNS side effects. Food does not affect absorption.
Simetrel is contraindicated in the first trimester; in the second and third trimesters by strict indications. Lactation is prohibited due to penetration into milk.
The drug may cause dizziness and hallucinations, which requires caution when driving.
In the elderly, the dose is reduced in case of impaired renal function. In children under 1 year of age do not use; older - with regard to body weight.